Phentermine Hydrochloride Capsules 30mg Recalled for cGMP Deviations
KVK Tech, Inc. is recalling 9,680 bottles of Phentermine Hydrochloride Capsules 30mg nationwide due to cGMP (current Good Manufacturing Practice) deviations. The recall is voluntary and firm-initiated.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The source indicates an FDA Class II recall for cGMP deviations. No hospitalizations, illnesses, or injuries are reported in the source text. cGMP deviations are manufacturing/process issues rather than direct health hazards, placing this in the Moderate category.
Plain-English summary
KVK Tech, Inc. is recalling Phentermine Hydrochloride Capsules, USP 30mg in 100-count bottles (NDC 10702-028-01) distributed nationwide. The recall affects lot numbers 18350A and 18351A with an expiration date of 6/30/2027, totaling approximately 9,680 bottles.
The recall has been initiated due to cGMP (current Good Manufacturing Practice) deviations. This is a voluntary, firm-initiated recall.
Consumers who have obtained this medication should contact their pharmacist or healthcare provider for guidance. Patients should not stop taking the medication without consulting their healthcare provider.
The recalled product
- Product
- PHENTERMINE HYDROCHLORIDE (PHENTERMINE HYDROCHLORIDE)
- Brand
- PHENTERMINE HYDROCHLORIDE
- Manufacturer
- KVK Tech, Inc.
- Hazard
- Affected units
- 9,680
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot#: 18350A
- 18351A
- Exp 6/30/2027
UPCs (3)
- 0310702027107
- 0310702028104
- 0310702026100
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by KVK Tech, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · PHENTERMINE HYDROCHLORIDE
- ModeratePD-Rx Recalls Phentermine Hydrochloride Capsules Due to Impurity Failures
FDA (Drugs) · 2017-08-30
- LowKVK-Tech Recalls Phentermine Hydrochloride Capsules Due to Impurity Failures
FDA (Drugs) · 2017-08-23
- LowPD-Rx Recalls Phentermine Hydrochloride Capsules Due to Impurity Failures
FDA (Drugs) · 2016-01-27
Same manufacturer · KVK Tech, Inc.
See all →- ModerateIndomethacin Extended-Release Capsules Recalled for cGMP Deviations
FDA (Drugs) · 2025-05-28
- SevereBetaxolol Hydrochloride tablets recalled due to oxycodone contamination
FDA (Drugs) · 2023-10-25
- SevereAtovaquone Oral Suspension Recalled for Temperature Abuse
FDA (Drugs) · 2021-09-01
- ModerateKVK-Tech Recalls Hydrocodone and Homatropine Tablets for Impurity Failures
FDA (Drugs) · 2021-05-26
- LowKVK-Tech Recalls Benzhydrocodone and Acetaminophen Tablets Due to Impurity
FDA (Drugs) · 2021-01-20
Same hazard · cgmp deviation
See all →- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02
- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- HighShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate USP Recalled for CGMP Deviations Noted During FDA Inspection
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate Recall Due to CGMP Deviations
FDA (Drugs) · 2026-08-19